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The health effects of radiation have been a focus for research since early in the 20th century. As
the century ends, extensive experimental and epidemiologic evidence has been accumulated
that addresses the adverse consequences of radiation exposure; epidemiologic studies of
radiation-exposed groups from the general population and specific occupational groups provide
quantitative estimates of the cancer risks associated with exposure. This report provides a
perspective on the extensive epidemiologic evidence on the health effects of ionizing radiation
and on likely needs for further epidemiologic research on radiation and health. Epidemiologic
studies have proved informative on the quantitative risks of radiation-caused cancer but we now
face the challenges of more precisely characterizing risks at lower levels of exposure and also of
assessing modifiers of the risks, including dose rate, genetic susceptibility, and other
environmental exposures. This report considers investigative approaches, such as pooled
analysis of multiple data sets, that can be used to address these complex questions and the
limitations of these approaches for addressing societal concerns about the risks of radiation
exposure. Environ Health Perspect 105(Suppl 4):883-889 (1997)
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Introduction
One hundred years have now elapsed since
Roentgen's 1895 discovery ofX-rays. In the
ensuing years, radiation has become widely
used for medical, industrial, and other pur-
poses. The world's population has been
exposed to radiation through its medical
uses and by radiation-emitting products,
employment in industries using radiation,
accidents, and nuclear weapons. Moreover,
it has been learned that most of the dose
received by the general population comes
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from natural and not man-made sources
(1,2). These natural sources include cosmic
rays, terrestrial radiation, and internally
deposited radionuclides (Table 1). Radon,
the sixth decay product ofuranium-238, is
the largest contributor to population dose.
Radon is ubiquitous in indoor environ-
ments, which it enters from the soil; its
short-lived progeny includes two alpha-
emitters, polonium-218 and polonium-
214, which internally irradiate the lung
when inhaled. Estimates of total radiation
exposure for the United States (Table 1)
show that radon contributes over half of
the estimated effective dose, and man-
made sources contribute less than 20% (1).
Although sufficient data are not available
for making similar estimates on a world-
wide basis, the conclusions in the 1988 and
1993 reports of the United Nations
Scientific Committees on the Effects of
Atomic Radiation (UNSCEAR) (2,3) on
the worldwide balance between exposure
from natural and man-made sources were
similar to that for the United States.
The health effects of radiation have
been a focus for research since early in
the 20th century. Radiation burns and
radiation sickness were quickly recognized
as early operators ofX-ray machines suf-
fered the consequences of high levels of
exposure (4). The problem of radiation-
caused skin cancers was also soon noted. By
mid-century, the potential for external irra-
diation and internally deposited radionu-
clides to cause cancer at other sites was
documented through the unfortunate expe-
riences of the underground miners in
Schneeberg and Joachimsthal in Central
Europe, the radium dial painters in the
United States, and the survivors of the
Hiroshima and Nagasaki atomic bomb
blasts inJapan.
Voluminous experimental and epidemi-
ologic evidence is now available on the
health effects ofradiation. Throughout the
world, government and nongovernment
agencies have used the epidemiologic data
to estimate the risks ofradiation as a basis
for setting limits for exposure; the comple-
menting experimental data have been used
to develop biologically appropriate risk
models and to support assumptions made
in analyzing and applying the epidemio-
logic findings. In the United States, the
Biological Effects of Ionizing Radiation
(BEIR) Committees of the National
Research Council and committees of the
National Council on Radiation Protection
and Measurements (NCRP) have periodi-
cally developed estimates of the risks
of various types of radiation exposure.
Similar types of estimates have also been
made by the International Commission for
Radiological Protection (ICRP) and
UNSCEAR. Increasingly sophisticated sta-
tistical approaches have been applied to the
epidemiologic data for this purpose, and
confidence in the risk estimates has
mounted as the extent ofthe epidemiologic
evidence and our understanding ofbiologic
mechanisms have grown.
Nevertheless, the health effects of
radiation remain a topic of widespread
societal concern in spite of the deepening
scientific knowledge. Risks ofmedical radi-
ation, nuclear facilities, and occupational
exposures have been questioned repeatedly
as to their acceptability; on the other hand,
these radiation exposures arise from essen-
tial societal applications oftechnology and
there is concern that the public could be
made too phobic of radiation by exagger-
ated risk estimates. Consequently, there
has been sustained questioning of the
epidemiologically based risk models.
For example, the recent recognition of
the magnitude of radon's contribution to
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Table 1. Average annual effective dose equivalent of iodizing regulations to a memberofthe U.S. population.
Dose equivalenta Effective dose equivalent
Source mSv mrem mSv %
Natural
Radonb 24 2400 2.0 55
Cosmic 0.27 27 0.27 8.0
Terrestrial 0.28 28 0.28 8.0
Internal 0.39 39 0.39 11
Total natural - - 3.0 82
Artificial
Medical
X-ray diagnosis 0.39 39 0.39 11
Nuclear medicine 0.14 14 0.14 4.0
Consumer products 0.10 10 0.10 3.0
Other
Occupational 0.009 0.9 <0.01 <0.3
Nuclearfuel cycle <0.01 <1.0 <0.01 <0.03
Fallout <0.01 <31.0 <0.01 <0.03
Miscellaneousc <0.01 <1.0 <0.01 <0.03
Total artificial - - 0.63 18
Total natural and artificial - - 3.6 100
"To soft tissues. bDose equivalent to bronchi from radon progeny. The assumed weighting factor forthe effective
dose equivalent relative to whole-body exposure is 0.08. CU.S. Department of Energy facilities, smelters, trans-
portation, etc. Data from the National Council on Radiation Protection and Measurements (1).
population dose has sparked national pro-
grams to reduce indoor levels. At the same
time, critics have labeled such programs
premature and called for more definitive
evidence that this known occupational car-
cinogen causes lung cancer in the general
population (5). They question the estima-
tion ofrisks for the population with linear
models derived from studies ofminers. In
the United States and some European
countries, research has also been directed at
electromagnetic fields and nonionizing
radiation generated by power lines, appli-
ances, and video display devices, including
computer monitors. While nonionizing
radiation is not considered in this review,
attention given to this topic by the media
may have raised the public's concern about
radiation in general.
Even though the evidence on the health
risks ofradiation is more extensive than for
most other environmental causes ofdisease,
a strong rationale for further epidemiologic
and experimental research is evident. The
public is asking for a more confident assur-
ance ofthe safety of radiation exposures,
and changing technology has created new
radiation sources that need investigation.
Management ofwastes from nudear power
generation and the clean-up of sites of
weapons development and production have
brought out the potential for exposures of
workers and ofthe general population. The
long half-lives ofsome ofthe radioisotopes
that have been generated pose an unprece-
dented need for safe storage over thousands
ofyears.
This report provides a perspective on
likely needs for further population-based
research on radiation and health; this
research will take place on a background of
advancing understanding of the mecha-
nisms bywhich radiation causes cancer and
ofthe genetic determinants ofsusceptibil-
ity. The article also forecasts areas in which
epidemiologic investigation will be needed
and the challenges that will be faced in
these investigations. Selected examples are
used to illustrate these predictions. The
article does not attempt to comprehen-
sively review the current status ofthe full
range ofevidence on radiation and disease;
a number ofcomprehensive reviews on this
topic are available (6-8).
Epidemiologic Findings
on the Risks of Ionizing
Radiation
Ionizing radiation is perhaps the best-
characterized human carcinogen. We
understand the physical nature of the
agent; we have an ever-deepening knowl-
edge ofthe mechanism ofcarcinogenesis;
we have well-developed animal models of
radiation-caused lung cancer; and we can
estimate cancer risks from radiation with a
reasonable degree ofcertainty. Exposures
can be measured and doses ofenergy deliv-
ered to tissues can be calculated. This
extensive knowledge has guided the devel-
opment ofradiation protection standards
through the work ofthe BEIR committees
and committees ofthe NCRP and ICRP.
Quantitative estimates ofthe risks have
been derived primarily from epidemiologic
studies ofradiation-exposed populations.
For low linear energy transfer (low-LET)
radiation, the study of the atomic bomb
survivors of Hiroshima and Nagasaki has
been a principal data source. This is a
prospective cohort study involving follow
up ofapproximately 93,000 survivors ofthe
atomic bombings and 27,000 additional
persons who lived in the two cities in 1950
but were not present at the time of the
blasts. The population was not enrolled
until 5 years had passed since the bomb-
ings, so survival for at least 5 years was
mandatory for enrollment in the cohort.
For each person, radiation exposure was
estimated based on location at the time of
the blast, shielding, and other factors.
Unique features ofthe population include
its size, the virtually instantaneous delivery
ofexposure at the time ofthe blast, and the
lengthy follow up. Initially, the participants
were followed for cancer mortality (9), but
incidence has nowbeen added (10,11).
Excess occurrence ofcancer is assessed
by comparing the number ofcancers among
cohort members exposed to radiation with
projections ofexpected numbers ofcases
based on the experience ofthe participants
who were not exposed. Quantitative esti-
mates ofrisk are made by applying regres-
sion models that calculate the relationship
ofthe excess risk beyond background with
exposure to radiation (or with estimated
organ dose). This approach was followed
by the BEIRV Committee (7) and in sub-
sequently reported analyses ofmortality for
1950 to 1987 (8) and for cancer incidence
for 1958 to 1987 (10,11). In the relative-
risk models used in these analyses, the risk
coefficients describe the relative increment
in risk beyond background per unit of
exposure. Positive coefficients are evident
for most sites ofsolid tumors; leukemias,
except for chronic lymphocytic leukemia,
were also in excess. Tracking cancer inci-
dence adds information on sites for which
cancers are infrequently fatal-thyroid,
skin, salivary gland, and new leukemias
and lymphomas. The excess risk coeffi-
cients derived from this study remain a
principal basis for estimating risks of
radiation-associated cancer.
We have also gained substantial
methodologic insights from the studies of
atomic bomb survivors. The data set has
been a challenge to analysts and an impetus
for the development and application ofnew
models for longitudinal analysis (9). The
lengthy follow up of the cohort provided
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opportunity to characterize the time
dependence ofrisk and to determine ifthe
excess should be considered additive or
multiplicative to the background risk. The
general tendency for the data to be better
fit by multiplicative models has led to the
now universal application of relative risk
models (12) and the extension of those
models to include time-dependent effects.
Throughout the study there have been
concerns about error in the exposure esti-
mates and misclassification ofcancer diag-
noses; in fact, dose estimates were revised
in 1986 and questions have been subse-
quently raised as to the assumptions
underlying these most recent revisions (9).
These concerns have sparked the applica-
tion ofstatistical methods for considering
the consequences of errors in diagnoses
(13) and exposure and dose (14).
For low-LET radiation, data from
numerous additional epidemiologic studies
now also supply site-specific estimates of
cancer risk. The participants in these studies
have been exposed either through therapeu-
tic radiation or through their jobs. For can-
cer of the breast, for example, the 1994
UNSCEAR report lists 10 populations in
addition to the atomic bomb survivors
(Table 2). These studies generally indicate
excess incidence ofbreast cancer, although
there is a wide range ofrisk coefficients and
substantial imprecision in some ofthe risk
estimates. However, these studies differ sub-
stantially in the quality ofthe dose estimates
and population characteristics that may
modify the risk ofradiation. For most other
cancer sites, risk estimates are also available
from a number ofstudies (7,8). The avail-
ability ofrisk estimates from studies other
than the atomic bomb survivors has gener-
allystrengthened confidence in estimates for
specific sites while deepening the characteri-
zation ofuncertainty. These additional risk
estimates have also proved useful in assess-
ing uncertainty associated with extending
estimates from the atomic bomb survivors
to otherpopulations.
To increase the informativeness of
epidemiologic studies, the data from indi-
vidual studies can be combined to more
precisely quantify risks; metaanalysis uses
the data at the level of the individual
studies, while pooled analysis combines the
data for individuals in different studies.
Increasingly sophisticated techniques have
been used to combine data from different
studies. The random-effects models that
have come into use for combining data
simultaneously consider the effect ofbeing
in a particular study and the effect ofthe
exposure(s) ofinterest, e.g., radiation.
Several recent analyses are illustrative.
The International Agency for Research on
Table2. Epidemiologic studies of ionizing radiation and breast cancer incidence.a
Observed Expected Mean dose, Average excess
Study cases cases Sv relative risk, Svlb
Life span study
Age at exposure
<20years 122 62.8 0.28 3.32(2.3-4.4)
>20years 173 137.1 0.27 0.98(0.4-1.6)
Time since exposure
5-19years 49 36.9 0.28 1.19
20-29 years 87 63.5 0.27 1.34
30-42 years 159 99.5 0.27 2.21
All 295 199.9 0.27 1.74(1.1-2.2)
Massachusetts tuberculosis fluoroscopy 142 107.6 0.79 0.40(0.2-0.7)
NewYorkacute postpartum mastitis 54 20.8 3.70 0.43(0.3-0.6)
Ankylosing spondylitis 26 16.1 0.50 1.24(0.3-2.5)
Swedish breast irradiation 115 28.8 8.46 0.35(0.3-0.4)
Cervical cancercase-control 953 1083.0 0.31 -0.2(<-0.2-0.3)
Without ovaries 91 82.6 0.3 0.33 (<-0.2-5.8)
Contralateral breast
Denmark 529 508.7 2.51 0.02 (<-0.1-0.2)
United States 655 550.4 2.82 0.07 (<-0.1-0.2)
Rochesterthymic irradiation 22 7.8 0.76 2.39(1.2-4.0)
Skin hemangioma 56 36.4 0.20 4.2(1.8-7.2)
Scoliosis 11 6.1 0.13 6.37(0.9-15)
Hodgkin's disease (Stanford) 25 6.1 -44.0 0.07 (0.04-0.11)
'Data based on UNSCEAR, AnnexA, Table 8 (8). b90% Cl in parentheses derived from published data for the life
span studyand using exact Poisson methodsforthe other studies.
Cancer (IARC) combined data from seven
cohort studies ofnuclear workers compris-
ing nearly 96,000 persons exposed to gener-
ally low doses oflow-LET radiation (below)
(15) and an earlier report described a pooled
analysis of data from workers at U.S.
Department ofEnergy facilities (16). The
IARC analyses pooled data assembled from
95,673 workers in seven cohorts in the
United Kingdom, Canada, and the United
States. Mortality from leukemias, exclusive
ofchronic lymphocytic leukemia, was sig-
nificantly increased while mortality from all
cancers exdusive ofleukemiawas not. Using
Poisson regression and a linear model for
excess relative risk (ERR), the ERRwas esti-
mated as 2.18 per Sv (90% confidence
interval CI, 0.1, 5.7) for the leukemias and
as -0.07 per Sv (90% CI -0.4, 0.3) for all
cancers except leukemia. The leukemia risk
was consistent with projections from the
BEIRV model. The analyses did not show a
significant association ofradiation dose with
all cancer mortality but CIs were wide, even
without fill consideration ofuncertainty in
the ERRestimates.
In other pooled analyses, Ron and
colleagues (17) assessed risk of thyroid
cancer following exposure to ionizing radi-
ation. Data from five cohort studies were
combined; for every subject in the cohorts,
information was obtained on dates of
birth and exposure, type ofexposure, num-
ber of exposures, individual thyroid dose
estimates, and development of thyroid
cancer. The data for those exposed under
age 15 were combined and analyzed with
Poisson regression models. The individual
studies had all shown significantly
increased risk but confidence limits on the
risk estimates were wide. The pooled ERR
per G was 7.7 (95% CI 2.1-28.7). The
CIs, calculated with a random effects
model, incorporated the uncertainty from
variation among the cohorts.
For high linear energy transfer (high-
LET) radiation, there is also a wealth of
information, derived from studies ofunder-
ground miners exposed to radon (6,18). At
least 12 cohort studies incorporate estimates
ofexposure to radon progeny. The BEIR
IV report provided a model for lung cancer
risk associated with radon exposure, based
on four of the cohorts; more recently,
Lubin and colleagues combined data from
11 studies (19,20).
This extensive epidemiologic database
on populations exposed to low- and
high-LET radiation leaves no doubt as
to the carcinogenicity of radiation and
provides quantitative risk estimates that are
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sufficiently precise for calculating risks of
exposures in the workplace and ofdiagnos-
tic uses of radiation. Current approaches
for limiting radiation exposures have long
been grounded in these risk estimates and
there is little controversy about the risks at
the selected exposure limits. On the other
hand, the inferences from the epidemio-
logic evidence as to the risks at the lower
range of the exposure distribution have
become highly controversial and the data
have proved less informative on issues of
increasing importance from the public pol-
icy perspective. The pooled analyses that
have been reported to date show that epi-
demiologic studies can be informative
about lower exposures ifsufficient data can
be amassed. Pooled analyses, like the [ARC
report on nuclear workers, can be used to
gauge whether or not projected risks deviate
appreciably from observed risks.
Future Challenges
for Understanding the
Risks of Ionizing Radiation
Dose-Response Relationship
atLowerDoses
For the purpose ofpublic health protection,
exposure- or dose-response relationships
derived from epidemiologic studies are used
to estimate the burden ofradiation-related
cancer for the general population and
exposed occupational groups. These esti-
mates are subject to uncertainty because
they are based on extrapolation of dose-
response relationships to ranges of dose
lower than those at which the observations
were made. For this purpose, linear no-
threshold models for the relationship
between dose and cancer risk are widely
used; this type ofmodel has been viewed as
biologically plausible and conservative in
protecting public health because risk is
attributed to all levels of exposure (21).
Some have viewed this model as greatly
exaggerating the risks and contributing to
public fear of radiation (22-24). Some
have called for a reconsideration of using
the linear no-threshold model for policy
purposes, arguing that the science is not
consistent and proposing that practical
thresholds may be found (25). The mount-
ing evidence on adaptive responses to radia-
tion is an additional consideration in regard
to the effects oflower radiation doses (8).
Some have proposed that lower doses of
radiation may carry no cancer risk or may
even reduce risk (hormesis) (26,27). On
the other hand, the 1994 UNSCEAR
report (8) concluded that the information
on adaptive responses ofcells did not have
implications with regard to late effects such
as cancer induction.
Using current epidemiologic approaches,
directlycharacterizing radiation risks atdoses
typically received by the general population
is a formidable and virtually unaddressable
challenge. To gain sufficient precision to
provide a meaningful characterization of
risk, extremely large study populations are
needed. For example, Land (28) estimated
sample size needs for a theoretical cohort
study designed to detect excess risk associ-
ated with an average tissue dose from a
single mammographic examination of 1
centigray to each breast. Power was not
adequate for sample sizes ofless than 100
million. For leukemia, a sample size of 16
million was projected for adequate power
and the same exposure. Characterizing the
shape of the dose-response relationship
would carry even more demanding data
requirements. Errors in exposure and the
confounding influences ofother causes of
cancer further complicate the assessment of
dose-response relationships at lowerdoses.
Determining the risks ofindoor radon
is another topical example. To date, the
principal approach for estimating the risks
ofindoor radon has been extension ofthe
dose-response relationship observed in
underground miners ofuranium and other
ores to the generally lower exposures ofthe
general population. Extrapolation to the
population's average exposure is across at
least one or two orders of magnitude of
cumulative dose. To more directly estimate
the risk ofindoor radon and thereby avoid
the uncertainty associated with using the
miner data, case-control studies oflung
cancer in the general population have
been undertaken. These studies involve
comparison of estimated exposures to
indoor radon with exposures of controls
who do not have lung cancer. Exposures are
estimated by making measurements in
current and past residences with the implicit
assumption that current concentrations
reflect those that gave rise to past exposures.
There is certain to be error because ofthis
assumption and this approach is further lim-
ited by the difficulty ofaccessing all prior
residences in most studies. Residential
mobility also reduces the variance ofexpo-
sure and thereby increases the needed sam-
ple sizes beyond projections based on the
distribution ofconcentrations in homes. In
spite ofthese methodologic problems, there
are a number of case-control studies of
indoor radon, some ofsubstantial size, that
are eithercompleted or in progress (12).
Lubin, Samet, and Weinberg (29)
estimated the sample sizes needed for case-
control studies ofindoor radon and lung
cancer. Two hypotheses are of potential
interest in such studies: the null hypothesis
that indoor radon does not cause lung
cancer; and the alternative hypothesis that
the risk ofindoor radon is substantially dif-
ferent from the projection based on the
miner data. For public policy purposes, the
latter hypothesis is ofmore interest because
observational evidence alone will not suf-
fice to dismiss indoor radon as a carcinogen
in view ofthe extensive data available from
miners and the state ofour understanding
of the biologic basis of radon's carcino-
genicity (6). Under realistic scenarios of
population mobility, these calculations
showed that thousands of participants
would be needed to address these hypothe-
ses (Table 3). Measurement error further
increases the needed number of cases and
controls. In a recent extension of these
analyses, Lubin, Boice, and Samet (30)
considered the likely informativeness of 10
case-control studies of indoor radon and
lung cancer, each with 700 cases and con-
trols and each representing the evidence
available at present. Their simulation
Table 3. Effect of measurement error and mobility pattern on sample size required to reject no trend with radon
exposure, f3o =0, when the true trend is Pi = 0.015.a
f
0.00
0.30
0.50
1.00
1.50
2.00
60 years
Cases Powerc
251 0.90
288 0.86
365 0.79
973 0.48
4,186 0.22
29,542 0.12
Mobilitypatternb
3 x 20 years
Cases Powerc
529 0.66
656 0.58
916 0.48
2,987 0.23
13,934 0.12
100,308 0.08
6x 10 years
Cases Powerc
938 0.46
1,303 0.37
2,050 0.28
8,002 0.14
39,456 0.09
287,644 0.07*
Abbreviations: 3, excess risk coefficient in units of percent per working level month of exposure; f, proportional
index of error on a logarithmic scale; data from Lubin et al., Table 5 (29). aStudy based on a control-to-case ratio
of 2. bNumber of, and duration at, residences in 60 years(e.g., 1 residence in 60years). CPower relative to a study
with 251 cases, 502 controls, and no error in exposure(f=0).
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analysis showed that a set ofstudies ofthis
size would provide little insight into radon
risk. By the end ofthe century, the pool of
case-control studies ofindoor radon and
lung cancer will include about 15,000 cases;
separate pooled analyses of the North
American and European studies are planned,
followed by a global pooling. However,
Lubin and colleagues (30) are pessimistic
about the prospects ofresolving issues of
quantitative risk from indoor radon with
pooledanalyses ofthe case-control data.
Pooling of data from higher-dose
studies of radiation-exposed workers and
therapeutically exposed persons has proved
informative because ofthe statistical power
gained beyond that of the individual
studies. The pooled analyses ofdata from
underground miners are illustrative. The
BEIR IV Alpha Committee (6) analyzed
data from four studies (Colorado Plateau,
Beaverlodge, and Ontario uranium miners
and Malmberget iron miners) that
included a total of360 lung cancer deaths.
Poisson regression analysis was used to fit a
series ofrelative risk models to the individ-
ual data sets and to the combined data.
The individual data sets were found to be
consistent and the committee reported a
preferred model based on the pooled data.
The model was multiplicative but the
effect ofexposure varied with interval since
exposure and with attained age. The model
represented a significant departure from
prior analyses, which had emphasized
either simple attributable risk or relative
risk models. The recent pooled analysis
extended this approach to the 11 cohorts
extant in the early 1990s that had individ-
ual exposure estimates and a significant
number of lung cancer cases (20). The
total population comprised about 68,000
men who had experienced 2700 lung
cancer deaths during follow up. This larger
sample size facilitated a more precise char-
acterization ofthe risk ofradon and added
a term to the model for an effect of dose
rate. Other illustrative analyses have been
reported for nuclear workers (15) and for
thyroid cancer following exposure to
external radiation (17).
Such pooled analyses would appear to
represent the optimum approach for future
assessments of the cancer risks associated
with lower levels of radiation. The antici-
pated pooling ofthe case-control studies of
indoor radon and lung cancer has been
facilitated by a series ofworkshops ofthe
investigators and a similar high level of
cooperation has been achieved for other
pooled analyses.
Dose-RateEffects
Typical radiation exposures ofthe general
population are sustained at lower dose rates
than those received by participants in the
epidemiologic studies. At the extreme, the
radiation from the atomic bomb blasts in
Hiroshima and Nagasaki was received
instantaneously. The radon-exposed
underground miners received exposures
across a range ofa few months to their full
working lifetimes, while radon exposure
indoors is continuous. Consequently, to
project radiation risks for the general popu-
lation, an assumption is needed as to the
effect ofdiffering dose rates for the observed
populations and the general population.
For low-LET radiation, risk estimates
derived at high doses and high dose rates
are reduced by the dose-rate reduction fac-
tor (7,8). While some studies provide infor-
mation on consequences ofdose rate, the
dose-rate reduction factors have been
empirically derived and their biologic and
epidemiologic basis remains uncertain (31).
It is not realistic to anticipate that epidemi-
ologic evidence will characterize dose-rate
reduction factors at the doses of greatest
concern for typical population exposures.
For high-LET radiation, there is both
experimental and epidemiologic evidence
that lower dose-rate exposures have
increased risk (inverse dose-rate effect)
(12,20). The recent pooled analysis ofdata
from underground miners showed that the
excess relative risk oflung cancer increased
as the exposure rate decreased. However,
the lowest dose-rate category in this analysis
is about two orders ofmagnitude above the
typical exposure rates for the general popu-
lation. Thus to estimate the risk posed by
residential radon, assumptions are needed
not only on the shape ofthe dose-response
relationship but also on the magnitude of
the dose-rate effect at typical environmen-
tal exposures. A simple extrapolation ofthe
estimated dose-rate effect from the miner
data would lead to unrealistically high risk
estimates. Brenner (32) has proposed a bio-
physical model that postulates a depen-
dence ofthe dose-rate effect on dose; this
model leads to the conclusion that a
dose-rate effect should not be present at
low doses. A recent analysis ofdata from
the 11 cohorts ofunderground miners is
consistent with this postulated dependence
ofthe inverse dose-rate effect on dose (19).
Dose-rate effects will remain a key
uncertainty in risk assessments. Large epi-
demiologic data sets can provide only a
limited characterization ofsuch effects at
lower doses, as exemplified by the pooled
analysis of underground miner data.
Further guidance is needed from research
findings on mechanisms ofcarcinogenesis.
Susceptibility
We are making rapid advances in our
understanding of the molecular basis of
carcinogenesis. Numerous genetic muta-
tions associated with increased cancer risk
have now been identified. The increasing
availability of genetic markers of cancer
risk brings the possibility of identifying
persons at increased risk for radiation-
related cancer in research studies and
potentially for limiting exposures ofthose
found susceptible. We have developed a
research paradigm, now widely referred to
as molecular epidemiology, that provides
an approach to assessing the combined
effect ofradiation exposure and susceptibil-
ity determinants. For example, in cohort
(longitudinal) studies, biological specimens
can be stored as the cohort is established,
or even while follow up is in progress, then
analyzed for susceptibility markers for
those developing cancer as well as for
appropriately matched controls.
Breast cancer may prove to be one of
the first successes of this approach. We
recently learned that a gene, BRCA1, is
responsible for a substantial proportion of
premenopausal breast cancer cases. Using
data from atomic bomb survivors younger
than age 20 at the blast, Land (33) has
shown that the pattern ofage-specific risks
ofbreast cancer is consistent with an inter-
action between radiation exposure and
genetic susceptibility. The estimated ERR
is far higher (ERR= 13.5) for women
developing breast cancer before age 35
than in those who have a later diagnosis
(ERR=2.0). This pattern implies the exis-
tence of a radiation-susceptible subgroup.
Land proposes that the role of BRCA1 (or
other genes) could be tested by using
archival or other tissues.
Inv gClusers
The landscape of the developed world
is now dotted with nuclear facilities:
nuclear power plants, uranium processing
plants, factories and laboratories concerned
with weapons development and manufac-
turing, and areas of waste storage. The
1988 UNSCEAR report (3) identified 417
nuclear reactors in use for power produc-
tion in 26 countries at the end of 1987.
Contamination has been found at long-
abandoned sites offactories where radia-
tion was used, and tailings piles (stacks
of residual ore and waste products) and
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radiation-containing lagoons remain in
areas where uranium was mined. The visi-
ble presence of these nuclear facilities
invites concern about the health conse-
quences of living in nearby locations.
Given the numbers ofsuch locations, clus-
ters of cancers with spatial distributions
consistent with causation by radiation or
other exposures linked to nuclear facilities
are inevitable. The sequence of investiga-
tions that followed the identification of
excess incidence of childhood leukemia
and other cancers in Seascale and other vil-
lages near the Sellafield nuclear site in the
United Kingdom is illustrative (34). The
cluster, first reported in a television pro-
gram, was quickly followed by confirma-
tion of increased leukemia mortality rates
for one of the adjoining districts (34).
This single cluster has prompted a remark-
able series ofdescriptive and analytic inves-
tigations and remains unexplained. The
single explanation linking the cluster to the
nudear facility-paternal exposure to radi-
ation-has not been sustained by studies
elsewhere (35). Other clusters, including a
clustering of brain cancer noted in Los
Alamos County, New Mexico, have also
received widespread attention.
A research methodology is needed for
prospectively identifying such clusters
and evaluating their public health signi-
ficance. Without such a methodology,
apparent clusters (which may not be actual
clusters) will almost certainly be recog-
nized, and public concern and media atten-
tion will demand investigations that may
tax local resources.
AssuringSafety
Accidental radiation releases, some of
catastrophic proportions like Chernobyl,
have been widely documented. Releases of
radiation into the general environment have
been investigated at a number oflocations
including, for example, Denver, Colorado,
adjacent to Rocky Flats; the area adjacent to
Three Mile Island; and regions exposed fol-
lowing the Chernobyl disaster. The effects
offallout on the community have also been
investigated. These investigations, under-
taken with some knowledge ofthe quanti-
ties ofradiation released and the likely doses
received, have several potential purposes:
providing evidence to the public ofthe con-
sequences ofexposure; providing assurance
to the public that the projected doses were,
in fact, low, and that adverse effects could
not be documented; and providing an
opportunity to test dose-response relation-
ships extrapolated from higher doses. The
conduct ofsome ofthese studies ofexposed
populations has been largely motivated by
the need to offer reassurance to the public
and to show evidence that an investigation
has been undertaken. Land (36) and
McMahon (37) have cautioned against
studies of populations with doses only
slightly higher than background, both argu-
ing that an unfavorable signal-to-noise
ratio assures uninformative and even mis-
leading results. New approaches to sharpen
the specificity ofstudies at low doses may
obviate thisjustifiable concern.
The experience gained from these studies
shows the limitations faced by observa-
tional studies at low doses. For example,
Hatch et al. (38) investigated cancer near
the Three Mile Island nuclear plant.
Modeled dispersion ofemissions was used
to estimate population doses. The average
increment-to-background dose was
estimated to be about 0.1 mSV, about 10%
ofthe annual dose. The upper limit was at
about a doubling ofannual dose. The find-
ings showed no changes in cancer incidence
indicative of an effect of the radiation
releases from the plant, but confidence lim-
its around risk measures were extremely
wide because ofthe small numbers ofcan-
cer cases. Reassurance for the public can be
found in the point estimates ofrisk, which
show no consistent evidence ofincrease; the
upper bounds ofthe CIs, however, extend
well into a range ofpublic health concern.
Unfortunately, accidental exposures
continue. Each should be assessed for the
need for surveillance and for more formal
epidemiologic investigations. The exposed
population needs to know the surveillance
data. Unanticipated excesses ofdisease may
then prompt follow-up investigation. For
example, there has been a dramatic increase
in childhood thyroid cancer in Belarus and
the Ukraine following the Chernobyl acci-
dent (39). This excess calls for investiga-
tion, including reconstruction ofdoses and
estimation ofdose-response relationships.
Conclusions
This review has emphasized research ques-
tions and methodologic advances related to
the cancer risk associated with radiation
exposure. It has emphasized key uncertain-
ties related to the risks ofradiation using
observational data: dose response, dose-rate
effects, and susceptibility. Advances have
been made in the epidemiologic approach
to quantifying the risk ofradiation expo-
sure, and mechanistic research promises to
further reduce uncertainties. We should
be able to address public concerns about
radiation with increasing confidence,
although the rising emphasis on the risks
oflower levels of exposure has increased
the challenge.
REFERENCES
1. NCRP. Ionizing Radiation Exposure ofthe Population ofthe
United States. Rpt no 93. Bethesda, MD:National Council on
Radiation Protection and Measurements, 1987;1.
2. United Nations Scientific Committee on the Effects ofAtomic
Radiation. Sources and Effects of Ionizing Radiation. New
York:United Nations Press, 1993;1.
3. United Nations Scientific Committee on the Effects ofAtomic
Radiation. Sources, Effects and Risks of Ionizing Radiation.
Annex F-Radiation Carcinogenesis in Man. New
York:United Nations Press, 1988.
4. Caufield C. Multiple Exposures. Chronicles ofthe Radiation
Age. London:Stoddard Publishing, 1989.
5. A elson PH. Editorial: Uncertainties about health effects of
radon. Science 250:353 (1990).
6. National Research Council Committee on the Biological
Effects of Ionizing Radiation. Health Risks of Radon and
Other Internally Deposited Alpha-emitters: BEIR IV.
Washington:National Academy Press, 1988.
7. National Research Council Committee on the Biological
Effects of Ionizing Radiation. Health Effects of Exposure to
Low Levels of Ionizing Radiation: BEIR V. Washington:
NationalAcademy Press, 1990.
8. United Nations Scientific Committee on the Effects ofAtomic
Radiation. Sources and Effects of Ionizing Radiation. New
York:United Nations Press, 1994;1.
9. Schull WJ. Effects ofAtomic Radiation. A Half-Century of
Studies from Hiroshima and Nagasaki. New York:Wiley-
Liss, 1995.
10. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M,
Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S et al.
Cancer incidence in atomic bomb survivors. Part II: solid
tumors, 1958-1987. Radiat Res 137:S17-S67 (1994).
888 Environmental Health Perspectives * Vol 105, Supplement 4 * June 1997IONIZING RADIATION AND CANCER
11. Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E,
Kuramoto A, Kamada N, Dohy H, Matsui T, Nonaka H et al.
Cancer incidence in atomic bomb survivors. Part III: leukemia,
lymphoma and multiple myeloma, 1950-1987. Radiat Res
137:S68-S97 (1994).
12. National Research Council Committee on Health Effects of
Exposure to Radon (BEIR VI) and Commission on Life
Sciences. Health Effects of Exposure to Radon: Time for
Reassessment? Washington:National Academy Press, 1994.
13. Sposto R, Preston DL, Shimizu Y, Mabuchi K. The effect of
diagnostic misclassification on non-cancer and cancer mortality
dose response in A-bomb survivors. Biometrics 48:605-617
(1992).
14. Pierce DA, Vaeth M. The shape of the cancer mortality
dose-response curve for the A-bomb survivors. Radiat Res
126:36-42 (1991).
15. IARC Study Group on Cancer Risk among Nuclear Industry
Workers. Direct estimates ofcancer mortality due to low doses
of ionising radiation: an international study. Lancet
344:1039-1043 (1994).
16. Gilbert ES, Cragle DL, Wiggs LD. Updated analyses of com-
bined mortality data for workers at the Hanford Site, Oak
Ridge National Laboratory, and Rocky Flats Weapons Plant.
Radiat Res 136:408-421 (1993).
17. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern
LM. Thyroid cancer after exposure to external radiation: a
pooled analysis of seven studies. Radiat Res 141:259-277
(1995).
18. Lubin JH, Boice JD Jr, Edling C, Hornung RW, Howe GR,
Kunz E, Kusiak RA, Morrison HI, Radford EP, Samet JM et
al. Lung cancer in radon-exposed miners and estimation ofrisk
from indoor exposure. J Natl Cancer Inst 87:817-827 (1995).
19. Lubin JH, Boice JD Jr, Edling C, Hornung RW, Howe G,
Kunz E, Kusiak RA, Morrison HI, Radford EP, Samet JM et
al. Radon and Lung Cancer Risk: A Joint Analysis of 11
Underground Miners Studies. Bethesda, MD:National
Institutes ofHealth, 1994.
20. Lubin JH, Boice JD Jr, Edling C, Hormung RW, Howe G,
Kunz E, Kusiak RA, Morrison HI, Radford EP, Samet JM et al.
Radon-exposed underground miners and inverse dose-rate (pro-
traction enhancement) effects. Health Phys 69A494-500 (1995).
21. Proctor RN. Cancer Wars. How Politics Shapes WhatWe Know
and Don't KnowAbout Cancer. NewYork:Basic Books, 1995.
22. Health Physics Society. Health Phys Soc Newslett 23(6):1-16
(1995).
23. Yalow RS. Radiation and public perception. In: Radiation and
Public Perception. Benefits and Risks (Young JP, Yalow RS,
eds.) Washington:American Chemical Society, 1995;1-12.
24. MuckerheideJ. The health effects oflow-level radiation: science,
data and corrective action. Nuclear News 38:26-34 (1995).
25. Goldman M. Cancer risk of low-level exposure. Science
271:1821-1882 (1996).
26. Luckey TD. Radiation Hormenesis. Boca Raton, FL:CRC
Press, 1991.
27. Kondo S. Health Effects ofLow-level Radiation. Osaka:Kinki
University Press, 1993.
28. Land CE. Estimating cancer risks from low doses of ionizing
radiation. Science 209:1197-1203 (1980).
29. Lubin JH, Samet JM, Weinberg C. Design issues in epidemio-
logic studies of indoor exposure to radon and risk of lung
cancer. Health Phys 59:807-817 (1990).
30. Lubin JH, Boice JD Jr, Samet JM. Errors in exposure assess-
ment, statistical power, and the interpretation of residential
radon studies. Radiat Res 144:329-341 (1995).
31. Nussbaum RH, Kohnlein W. Inconsistencies and open ques-
tions regarding low-dose health effects of ionizing radiation.
Environ Health Perspect 102:656-667 (1994).
32. Brenner DJ. The significance ofdose rate in assessing the haz-
ards ofdomestic radon exposure. Health Phys 67:76-79 (1994).
33. Land CE. Studies of cancer and radiation dose among atomic
bomb survivors. 274:402-407 (1995).
34. Beral V, Roman E, Bobrow M, eds. Childhoood Cancer and
Nuclear Installations. London:BMJ Publishing Group, 1993.
35. Beral V, Roman E, Bobrow M, eds. Introduction. In:
Childhood Cancer and Nuclear Installations. London:BMJ
Publishing Group, 1993;xxiii-xxxiii.
36. Land CE. New understanding from epidemiology-the next
25 years. Health Phys 55:269-278 (1988).
37. MacMahon B. Some recent issues in low-exposure radiation
epidemiology. Environ Health Perspect 81:131-135 (1989).
38. Hatch MC, Beyea J, Nieves JW, Susser M. Cancer near Three
Mile Island nuclear plant: radiation emmissions. Am J
Epidemiol 132:397-412 (1990).
39. Stsjazhko VA, Tsyb AF, Tronko ND, Souchkevitch G,
Baverstock KF. Childhood thyroid cancer since the accident at
Chernobyl. Br MedJ 310:801 (1995).
Environmental Health Perspectives * Vol 105, Supplement 4 * June 1997 889